Thermo Fisher lung cancer test wins expanded approval in Japan - MedTech Dive
Thermo Fisher lung cancer test wins expanded approval in Japan MedTech Dive
Thermo Fisher Scientific said it has received expanded approval in Japan for its companion diagnostic test for non-small cell lung cancer (NSCLC) therapies.
Comments
Post a Comment